Akademisyen
LEYLA ÖZER
PROFESÖR
İSTANBUL AREL ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 38
- Proje 0
- Kitap 4
- Bildiri 41
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
12
Q2
9
Q3
7
Q4
3
WoS (JCR)
Q1
2
Q2
6
Q3
9
Q4
14
TR Index
3
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
2
Ort. yüzdelik
74.3%
Üst %1 payı
0.0%
Üst %10 payı
7.4%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2014 Does beta blocker therapy improve the survival of patients with metastatic non small cell lung cancer YÖKSİS SJR Q2 JCR Q3
- 2014 Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma YÖKSİS SJR Q1 JCR Q2
- 2014 The Behavior of Turkish Cancer Patients in Fasting During the Holy Month of Ramadan YÖKSİS SJR Q1 JCR Q3 OpenAlex 69.1%
- 2014 High serum transforming growth factor beta 1 TGFB1 level predicts better survival in breast cancer YÖKSİS SJR Q1 JCR Q2 OpenAlex 76.9%
- 2014 Effect of carvedilol on silent anthracycline induced cardiotoxicity assessed by strain imaging A prospective randomized controlled study with 6 month follow up YÖKSİS SJR Q2 JCR Q4 OpenAlex üst %10 OpenAlex 90.2%
- 2014 Coagulation tests show significant differences in patients with breast cancer YÖKSİS SJR Q1 JCR Q2 OpenAlex 76.8%
- 2014 Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma YÖKSİS TR Index JCR Q4 OpenAlex 60.8%
- 2014 Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma YÖKSİS SJR Q2 OpenAlex 75.4%
- 2014 The Outcome of Patients with Triple Negative Breast Cancer The Turkish Oncology Group Experience YÖKSİS TR Index SJR Q4 OpenAlex 54.9%
- 2013 Biweekly triplet chemotherapy with gemcitabine cisplatin and vinorelbine for advanced chemotherapy naïve non small cell lung cancer YÖKSİS SJR Q2 JCR Q4
- 2013 Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma YÖKSİS JCR Q4 OpenAlex 77.1%
- 2013 Oral etoposide as first line therapy in the treatment of patients with advanced classic Kaposi s sarcoma CKS a single arm trial oral etoposide in CKS YÖKSİS SJR Q1 JCR Q1 OpenAlex 49.4%
- 2013 Clinical and Prognostic Significance of Coagulation Assays in Advanced Epithelial Ovarian Cancer YÖKSİS SJR Q2 JCR Q2 OpenAlex 66.0%
- 2013 Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection can we avoid radiotherapy in a subgroup of patients YÖKSİS SJR Q1 JCR Q3 OpenAlex 81.4%
- 2013 Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib YÖKSİS SJR Q3 JCR Q4
- 2013 Effect of increased body mass index BMI on time to tumour progression TTP in unresectable metastatic colorectal cancer mCRC patients treated with bevacizumab based therapy YÖKSİS SJR Q1 JCR Q3 OpenAlex 79.5%
- 2013 Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma YÖKSİS SJR Q2 JCR Q3 OpenAlex 69.2%
- 2013 The role of surgical methods in the treatment of anorectal malignant melanoma AMM YÖKSİS SJR Q3 JCR Q4
- 2013 Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies A Comparison of Chemotherapy Associated Myelotoxicity in Patients With Advanced Ovarian and Non Small Cell Lung Cancer YÖKSİS
- 2013 Two different formulations with equivalent effect Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients YÖKSİS SJR Q1 JCR Q3 OpenAlex 67.7%